Modern patients have an interest in and expectation of playing a part in their own health matters, enabled by new digital connections and advanced technology. In this emerging Medicine 2.0 era, as healthcare starts to harness this in earnest, the scope for personalised treatment becomes significant. ProductLife Group’s Loetitia Jabri asks where this is heading, and what challenges might crop up for medical device manufacturers.